Frederick Luk
Impact in
- Molecular Medicine top 1%
- Curcumin's Biomedical Applications
- Cancer Research top 5%
- MicroRNA in disease regulation
Papers in
-
- RNA Interference and Gene Delivery 8
- Extracellular vesicles in disease 6
- Advanced biosensing and bioanalysis techniques 1
- Oncology 8
- Drug Transport and Resistance Mechanisms 6
- Co-authors
- Mary Bebawy (14 shared papers)Richard Callaghan (1 shared paper)Ritu Jaiswal (7 shared papers)Rebecca S. Mason (2 shared papers)Wing‐Hin Lee (2 shared papers)Ramin Rohanizadeh (2 shared papers)Ching‐Yee Loo (2 shared papers)Georges E. Grau (5 shared papers)
- Journals
- Neoplasia (1 paper)Seminars in Cell and Developmental Biology (1 paper)Current Neuropharmacology (1 paper)Journal of Biomedical Nanotechnology (1 paper)Journal of Extracellular Vesicles (1 paper)
- Partner nations
- AustraliaUnited KingdomUnited States
In The Last Decade
Frederick Luk
16 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 104
- Molecular Medicine 306
- Cancer Research 402
- Pharmaceutical Science 85
- Oncology 371
- Biomaterials 177
Countries citing papers authored by Frederick Luk
This map shows the geographic impact of Frederick Luk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick Luk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick Luk more than expected).
Fields of papers citing papers by Frederick Luk
This network shows the impact of papers produced by Frederick Luk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick Luk. The network helps show where Frederick Luk may publish in the future.
Co-authors
The 25 scholars most cited alongside Frederick Luk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 419 | |
| 2 | 2014 | 363 | |
| 3 | 2013 | 92 | |
| 4 | 2012 | 89 | |
| 5 | 2014 | 74 | |
| 6 | 2013 | 71 | |
| 7 | 2013 | 67 | |
| 8 | 2015 | 62 | |
| 9 | 2016 | 53 | |
| 10 | 2015 | 45 | |
| 11 | 2014 | 45 | |
| 12 | 2013 | 43 | |
| 13 | 2014 | 33 | |
| 14 | 2016 | 29 | |
| 15 | 2011 | 28 | |
| 16 | New gene groups associated with dissimilar osteoblastic differentiation are linked to osteosarcomagenesis. | 2011 | 4 |
About Frederick Luk
Frederick Luk is a scholar working on Molecular Biology, Oncology, Cancer Research, Biomaterials and Molecular Medicine, having authored 16 papers that have together received 1.5k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (8 papers), MicroRNA in disease regulation (6 papers), Extracellular vesicles in disease (6 papers), Drug Transport and Resistance Mechanisms (6 papers), Nanoparticle-Based Drug Delivery (3 papers), Curcumin's Biomedical Applications (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Advanced biosensing and bioanalysis techniques (1 paper). The work is most often cited by research in Molecular Medicine (306 citations), Cancer Research (402 citations), Pharmaceutical Science (85 citations), Oncology (371 citations) and Biomaterials (177 citations). Frederick Luk has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Mary Bebawy, Richard Callaghan, Ritu Jaiswal, Rebecca S. Mason, Wing‐Hin Lee, Ramin Rohanizadeh, Ching‐Yee Loo, Georges E. Grau, Joyce Gong and Alison T. Ung. Their work appears in journals such as Neoplasia, Seminars in Cell and Developmental Biology, Current Neuropharmacology, Journal of Biomedical Nanotechnology and Journal of Extracellular Vesicles.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.